Dr. Camoriano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
- University of New England College of Osteopathic MedicineClass of 2011
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1985 - 1988
- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1982 - 1985
Certifications & Licensure
- AZ State License 1989 - 2025
- MN State License 1985 - 2001
- OK State License 1983 - 1985
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors:Arizona State Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin Start of enrollment: 2007 Mar 01
- Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer Start of enrollment: 2016 Jul 08
Publications & Presentations
PubMed
- Telemedicine and Patient Experience Ratings at an Academic Integrative Medicine Practice: Retrospective Examination.Ellen Meltzer, Laurie Wilshusen, Isra Abdulwadood, Claire Yee, Amy Sherman
JMIR Formative Research. 2024-07-22 - 3 citationsPregnancy in patients with myelofibrosis: Mayo–Florence series of 24 pregnancies in 16 womenNaseema Gangat, Paola Guglielmelli, Aref Al-Kali, Alexandra P. Wolanskyj-Spinner, John K. Camoriano
British Journal of Haematology. 2021-06-14 - 46 citationsPhase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancersGerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R. Foster, Erik Asmus
ESMO Open. 2020-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: